Skip to main content
. 2015 Oct 10;7(10):4067–4082. doi: 10.3390/toxins7104067

Figure 3.

Figure 3

In vitro activity of dDTEGF13: (A) Bispecific DTEGF13 and its monospecific counterparts were tested and compared for their reactivity against MiaPaCa-2 cells. Proliferation assays were performed by analyzing 3H-thymidine uptake after a 72-h incubation with targeted toxins. Data are reported as percent control response. Each data point represents an average of triplicate measures ± SD; (B) Deimmunized DTEGF13 and non-mutated parental DTEGF13 were tested and compared for activity against HT-29 colon; and (C) PC-3 prostate carcinoma cells in thymidine uptake assays. Two batches are used for reproducibility; (D) A blocking assay was performed in which MiaPaca-2 pancreatic cancer cell lines were incubated with an inhibitory dose of dDTEGF13 and then blocked with increasing concentration of EGF13 ligand devoid of toxin. Thymidine uptake was then measured. The non-specific recombinant α-Ly5.2 was included as a negative blocking control.